Sabba Stephen L 4
4 · LIGAND PHARMACEUTICALS INC · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Sabba Stephen L
Director
Transactions
- Award
Common Stock
2023-06-09+1,142→ 26,926 total - Award
Non-Qualified Stock Option (right to buy)
2023-06-09−5,461→ 5,461 totalExercise: $73.76Exp: 2033-06-09→ Common Stock (5,461 underlying)
Footnotes (2)
- [F1]These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.
- [F2]These securities, as represented in Column 5, were acquired by a grant of 5,461 shares approved by the Board of Directors of the Company at the 2023 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.